Mucocutaneous lymphangiomatosis and thrombocytopenia

Clinical trials for Mucocutaneous lymphangiomatosis and thrombocytopenia explained in plain language.

Never miss a new study

Get alerted when new Mucocutaneous lymphangiomatosis and thrombocytopenia trials appear

Sign up with your email to follow new studies for Mucocutaneous lymphangiomatosis and thrombocytopenia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Could a transplant drug tame tough vascular birthmarks?

Disease control Completed

This phase 2 trial tested the drug sirolimus (rapamycin) in 61 children and young adults with complicated vascular anomalies—abnormal blood vessel growths that can cause pain, bleeding, or organ problems. The goal was to see if sirolimus could safely shrink these anomalies and im…

Matched conditions: MUCOCUTANEOUS LYMPHANGIOMATOSIS AND THROMBOCYTOPENIA

Phase 2 • Sponsor: Denise Martin Adams • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC

Mucocutaneous lymphangiomatosis and thrombocytopenia

Get alerted when new Mucocutaneous lymphangiomatosis and thrombocytopenia trials appear

Could a transplant drug tame tough vascular birthmarks?